Boosting airway T-regulatory cells by gastrointestinal stimulation as a strategy for asthma control

Mucosal Immunol. 2011 Jan;4(1):43-52. doi: 10.1038/mi.2010.43. Epub 2010 Jul 28.

Abstract

The hallmark of atopic asthma is transient airways hyperresponsiveness (AHR) preceded by aeroallergen-induced Th-cell activation. This is preceded by upregulation of CD86 on resident airway dendritic cells (DCs) that normally lack competence in T-cell triggering. Moreover, AHR duration is controlled via T-regulatory (Treg) cells, which can attenuate CD86 upregulation on DC. We show that airway mucosal Treg/DC interaction represents an accessible therapeutic target for asthma control. Notably, baseline airway Treg activity in sensitized rats can be boosted by microbe-derived stimulation of the gut, resulting in enhanced capacity to control CD86 expression on airway DC triggered by aeroallergen and accelerated resolution of AHR.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Asthma / immunology*
  • Asthma / microbiology
  • Asthma / therapy*
  • B7-2 Antigen / genetics
  • Bacteria / cytology
  • Bacteria / immunology*
  • Bacteria / metabolism
  • Bronchial Hyperreactivity / immunology
  • Bronchial Hyperreactivity / therapy
  • CD4-Positive T-Lymphocytes / immunology
  • Cell Extracts / immunology*
  • Cell Extracts / therapeutic use
  • Cytokines / immunology
  • Dendritic Cells / immunology
  • Disease Models, Animal
  • Forkhead Transcription Factors / metabolism
  • Gastrointestinal Tract / immunology*
  • Gastrointestinal Tract / microbiology
  • Interleukin-2 Receptor alpha Subunit / immunology
  • Rats
  • Respiratory System / immunology*
  • T-Lymphocytes, Helper-Inducer / immunology
  • T-Lymphocytes, Regulatory / immunology*

Substances

  • B7-2 Antigen
  • Broncho-Vaxom
  • Cell Extracts
  • Cytokines
  • Forkhead Transcription Factors
  • Foxp3 protein, rat
  • Interleukin-2 Receptor alpha Subunit